文献速递颈动脉与弓上血管

经颈动脉血运重建与颈动脉内膜剥脱术的单中心结局比较

Outcomes of Transcarotid Artery Revascularization and Carotid Endarterectomy at a Single Institution.
PubMed 文献 · Ann Vasc Surg · 2020-11-26

该单中心回顾性研究基于血管质量倡议数据库,比较2012–2019年66例TCAR与501例CEA患者的围术期结局。TCAR患者合并症更多,但两组手术相关卒中无统计学差异(0% vs. 1.0%,P=0.42),TCAR组无围术期死亡、心梗、颅神经损伤或血肿。结论提示在选定患者中TCAR安全可行。

要点

  • TCAR与CEA手术相关卒中率无统计学差异(0% vs. 1.0%,P=0.42)。
  • TCAR组无围术期死亡、心梗、颅神经损伤或血肿。
  • TCAR患者合并症多于CEA患者,但围术期并发症相当。

核心结论

  • 在选定患者或解剖条件合适者中,TCAR的围术期手术相关卒中及心梗、颅神经损伤、血肿、死亡等并发症发生率与CEA相当。
  • TCAR可作为颈动脉狭窄的安全、可行的血运重建选择。

研究设计与样本

  • 单中心回顾性研究,基于前瞻性维护的血管质量倡议数据库。
  • 纳入2012年至2019年接受TCAR或CEA的患者,共66例TCAR(2018年2月至2019年12月)和501例CEA(2012年1月至2019年12月)。

主要发现

  • TCAR患者合并症发生率高于CEA患者。
  • TCAR组无手术相关卒中;CEA组手术相关卒中率为1.0%,两组差异无统计学意义(P=0.42)。
  • CEA组有5例手术相关卒中由技术问题导致目标血管血栓形成,另有3例卒中与手术无关。
  • TCAR组无围术期死亡、心梗、颅神经损伤或血肿。
  • 两组均无手术部位感染、假性动脉瘤或动静脉瘘并发症。

临床怎么用

  • 对于颈动脉狭窄患者,TCAR可作为一种安全可行的血运重建选项,尤其适用于解剖条件合适者。
  • TCAR患者合并症较多,但围术期并发症与CEA相当,选择术式时可综合考虑。

局限性

  • 单中心回顾性研究,样本量有限(TCAR 66例,CEA 501例)。
  • TCAR与CEA的纳入时间段不同(TCAR 2018–2019,CEA 2012–2019)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are accepted revascularization modalities to treat carotid artery stenosis. Higher incidences of perioperative adverse neurological events and death have been reported in patients with transfemoral CAS. Transcarotid artery revascularization (TCAR) is a newer operative technique that involves direct transcervical carotid access, mitigating aortic arch manipulation and minimizing the risk of embolic stroke via cerebral blood flow reversal. Perioperative stroke, myocardial infarction (MI), and death rates have been shown to be similar between TCAR and CEA, with TCAR having fewer complications. The objective of this study was to ascertain the safety and viability of TCAR by evaluating perioperative outcomes. We hypothesized that patients undergoing TCAR and CEA have equivalent outcomes. METHODS: We performed a single-institution retrospective review of a prospectively maintained Vascular Quality Initiative database on patients who underwent TCAR or CEA between 2012 and 2019. A total of 66 TCAR cases from February 2018 to December 2019 and 501 CEA cases from January 2012 to December 2019 were reviewed. Preoperative, intraoperative, and postoperative characteristics as well as perioperative outcomes were captured for the statistical analyses. RESULTS: From 2012 to 2019, 567 patients underwent TCAR or CEA. Patients who underwent TCAR were found to have higher rates of comorbidities compared with CEA. There were no procedure-related strokes in patients who underwent TCAR. There was no statistically significant difference between TCAR and CEA procedure-related strokes (0% vs. 1.0%, P = 0.42). There were 5 CEA procedure-related strokes because of technical problems resulting in thrombosis of the target vessels. Three patients who underwent CEA had strokes unrelated to the operations. Overall, there were no perioperative deaths, MI, cranial nerve injury (CNI), or hematoma in patients who underwent TCAR. There were no complications of surgical site infection, pseudoaneurysm, or arteriovenous fistula among patients who underwent TCAR or CEA. CONCLUSIONS: This single-center retrospective analysis of TCAR and CEA for the treatment of carotid artery disease suggests TCAR can result in equivalent perioperative procedure-related stroke as CEA as well as equivalent incidence of perioperative complications including MI, CNI, hematoma, and death in selected patients or patients with proper anatomy. TCAR may be considered a safe, feasible carotid revascularization option for carotid artery stenosis.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cappellini CA, Zheng H, Lamb KM, et al. Outcomes of Transcarotid Artery Revascularization and Carotid Endarterectomy at a Single Institution. Ann Vasc Surg. 2020. PMID: 33248241. doi:10.1016/j.avsg.2020.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。